[HTML][HTML] The next pandemic catastrophe: can we avert the inevitable?
The world faced an unprecedented health crisis due to the spread of the coronavirus
pandemic. Over 756 million confirmed cases and over 6.8 million fatalities had been …
pandemic. Over 756 million confirmed cases and over 6.8 million fatalities had been …
The deceptive COVID-19: lessons from common molecular diagnostics and a novel plan for the prevention of the next pandemic
DS Mouliou - Diseases, 2023 - mdpi.com
The COVID-19 pandemic took place during the years 2020–2022 and the virus, named
SARS-CoV-2, seems likely to have resulted in an endemic disease. Nevertheless …
SARS-CoV-2, seems likely to have resulted in an endemic disease. Nevertheless …
Leveraging environmental microbial indicators in wastewater for data-driven disease diagnostics
Introduction Wastewater-based surveillance (WBS) is an emerging tool for monitoring the
spread of infectious diseases, such as SARS-CoV-2, in community settings. Environmental …
spread of infectious diseases, such as SARS-CoV-2, in community settings. Environmental …
[HTML][HTML] Application of Machine Learning Prediction of Individual SARS-CoV-2 Vaccination and Infection Status to the French Serosurveillance Survey From March …
S Bougeard, A Huneau-Salaun, M Attia… - JMIR Public Health and …, 2023 - jmir.org
Background: The seroprevalence of SARS-CoV-2 infection in the French population was
estimated with a representative, repeated cross-sectional survey based on residual sera …
estimated with a representative, repeated cross-sectional survey based on residual sera …
Immunogenicity of Tetravalent Protein Vaccine SCTV01E-2 against SARS-CoV-2 EG. 5 Subvaraint: A Phase 2 Trial
J Tang, Q Xu, C Zhu, K Xuan, T Li, Q Li, X Pang, Z Zha… - Vaccines, 2024 - mdpi.com
The Omicron EG. 5 lineage of SARS-CoV-2 is currently on a trajectory to become the
dominant strain. This phase 2 study aims to evaluate the immunogenicity of SCTV01E-2, a …
dominant strain. This phase 2 study aims to evaluate the immunogenicity of SCTV01E-2, a …
Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients
L Zhang, J Yang, C Lai, L Wan, S **ong… - Frontiers in …, 2023 - frontiersin.org
Background A third mRNA vaccine booster is recommended to improve immunity against
SARS-CoV-2 in kidney transplant recipients (KTRs). However, the immunity against SARS …
SARS-CoV-2 in kidney transplant recipients (KTRs). However, the immunity against SARS …
Machine Learning at the Service of Survival Analysis: Predictions Using Time-to-Event Decomposition and Classification Applied to a Decrease of Blood Antibodies …
L Štěpánek, F Habarta, I Malá, L Štěpánek… - Mathematics, 2023 - mdpi.com
The Cox proportional hazard model may predict whether an individual belonging to a given
group would likely register an event of interest at a given time. However, the Cox model is …
group would likely register an event of interest at a given time. However, the Cox model is …
Evaluation of Mutual Information and Feature Selection for SARS-CoV-2 Respiratory Infection
S Kidambi Raju, S Ramaswamy, MM Eid, S Gopalan… - Bioengineering, 2023 - mdpi.com
This study aims to develop a predictive model for SARS-CoV-2 using machine-learning
techniques and to explore various feature selection methods to enhance the accuracy of …
techniques and to explore various feature selection methods to enhance the accuracy of …
Detecting the most critical clinical variables of COVID-19 breakthrough infection in vaccinated persons using machine learning
Background COVID-19 vaccines offer different levels of immune protection but do not
provide 100% protection. Vaccinated persons with pre-existing comorbidities may be at an …
provide 100% protection. Vaccinated persons with pre-existing comorbidities may be at an …
A SARS-CoV-2 peptide antigen purified from bacteria and displayed in a high-density repetitive manner on a virus-like particle could generate anti-SARS-CoV-2 …
F Begum, S Chandra, MH Mallik, J Dey… - Biochemical and …, 2024 - Elsevier
SARS-CoV-2 is an enveloped virus. Proteins of the lipid based envelope are not rigidly
arranged as compared to non-enveloped viruses lacking lipid based outer layer. Rigidly …
arranged as compared to non-enveloped viruses lacking lipid based outer layer. Rigidly …